Apollomics (APLM) Notes Payables (2023 - 2025)

Apollomics (APLM) posted quarterly Notes Payables of $124000.0 for Q4 2025, up 21.57% year-on-year from $102000.0 in Q4 2024, and down 74.49% on a QoQ basis from $486000.0 in Q2 2025.

Apollomics (APLM) Notes Payables (2023 - 2025) Analysis & Trends

Apollomics (APLM) has reported Notes Payables for 3 consecutive years, with $124000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Notes Payables rose 21.57% year-over-year to $124000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $124000.0 (up 21.57% YoY) and the FY2025 annual result came in at $124000.0, up 21.57% from the prior year.
  • Notes Payables slipped to $124000.0 in Q4 2025 per APLM's latest filing, from $486000.0 in the prior quarter.
  • Over the last five years, Notes Payables for APLM reached as high as $4.2 million in Q4 2023 and fell as low as $102000.0 in Q4 2024.
  • A 3-year average of $1.7 million and a median of $486000.0 in 2025 frame the typical range for Notes Payables.
  • Annual changes were most pronounced in 2024 — Notes Payables tumbled 97.59% — and 2025, when it grew 21.57%.
  • Year by year, Notes Payables stood at $4.2 million in 2023, then slumped by 97.59% to $102000.0 in 2024, then grew by 21.57% to $124000.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods registered $124000.0, $486000.0, and $102000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Apollomics 2.66 Bn 2.66 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 124,000.00
Jun 30, 2025 486,000.00
Dec 31, 2024 102,000.00
Jun 30, 2024 3.51 Mn
Dec 31, 2023 4.24 Mn